Skip to content

For patients

Get the answers you need with our extensive genetic testing.

Order a test

It can be frustrating to explore uncertainties on your own.

When it comes to your health, or that of your loved ones, you may want to make sure you explore all possible options. Our whole genome diagnostic testing is designed to help uncover critical information other tests could have missed.

Whole genome coverage

Our whole genome sequencing platforms provide an extensive analysis of your genomic makeup — for answers you can trust.

Targeted panel sequencing

< 0.1 %

Genome-wide coverage

  • Limited number of point mutations
  • Limited copy number variations
  • Limited structural variations

Whole exome sequencing

1 – 2 %

Genome-wide coverage

  • Limited number of point mutations
  • Limited copy number variations
  • Limited structural variations
  • Non-coding areas not covered

Whole genome sequencing

> 99 %

Genome-wide coverage

  • More point mutations identified
  • More accurate, genome-wide copy number variations
  • Genome-wide coverage of structural variations
  • Non-coding areas also covered
dr with patient

Easy-to-understand reports

Your detailed and easy-to-understand report will provide insights to help you and your healthcare provider make informed decisions tailored to your unique body, empowering you on your healthcare journey.

Genetic counseling support

You get automatic access to a genetic counselor to guide you through your results. We’ll make sure you understand the findings and potential treatment options and get the support you need.

dr with patient
dr with patient

Clinical trial matching support

We identify clinical trial matches based on your biomarkers and additional criteria and can connect you with enrollment support services.

* Note – Clinical trial matching support is currently available only for cancer patients using CancerVision. We are working to expand it to other disease areas.

Our tests

Whether you’re looking for more answers, treatment options, or support for a diagnosis, our tests are here to help.

Cancer

See your cancer from new angles.

Learn more

Rare disease

Shorten the time to get the right diagnosis.

Learn more

How to order a test

If you need support, email us at inquiry@inocras.com. We can help facilitate the process by working with you.

Sign up

Fill out the order request form, choose your preferred sample collection method, and consent form at inocras.com.

Clinical request

An external clinician will review and approve your test request.

Sample collection

Once your test request is approved, we’ll send you a link to make an appointment for a phlebotomist to visit your home and draw your blood. If you order a RareVision test and choose to provide a buccal (cheek) swab instead of blood, we’ll send you a kit with instructions for you to collect your sample.

Tumor tissue sample collection

If a tissue sample is needed based off the information you provide, we will work with your care team/pathologists’s office to collect it. No action is required from you.

*Tumor samples are only required for CancerVision

genetic-counselor-appointment

Genetic counselor appointment

You will get a notification when your report is ready. Go to the link we send to you and make an appointment with a genetic counselor to review your result.

Result review

Genetic counselor will review your CancerVision report and clinical trial matching report with you.

*Clinical trial matching is only for patients using CancerVision.

patient stories

Breast cancer patient finds hope in new treatment options

Diagnosed with pancreatic cancer at age 40, Kate had previously been successfully treated for breast cancer at 20. Several genetic tests, including a tissue panel test and hereditary cancer panel test, failed to reveal the root cause of her disease and why she got two different types of cancer at different points in her life. The CancerVision test provided a breakthrough. We discovered Kate had a genetic mutation in a gene called BRCA1. This mutation was present from Kate’s birth and contributed to her breast cancer by impairing her body’s ability to repair DNA damages that could lead to other cancers. The CancerVision findings created more informed treatment options for Kate and gave her a clearer picture of what was causing her cancer at a genetic level.

patient

patient stories

Teen receives definitive diagnosis & possible cure

Chloe, 17, had severe symptoms that affected her intestines. Doctors suspected inflammatory bowel disease (IBD), but finding the exact cause remained a challenge. The results from our whole genome sequencing test revealed two pathogenic variants that confirmed her diagnosis of early-onset IBD. She learned that IBD caused by her mutations can be treated, and even cured, through hematopoietic stem cell transplantation. She is now actively preparing for transplantation, a potential solution for her condition.

young woman with a cap

patient stories

Lung cancer patient sees improved prognosis with targeted treatment

John, 40, diagnosed with lung cancer, experienced a frustrating setback when the drug prescribed for his EGFR mutation failed to slow down the cancer’s progression. Feeling hopeless, he turned to the CancerVision test for a potential breakthrough. The test revealed a genetic alteration in a non-coding area (NTRK3::EML4 Fusion) that would have been difficult to detect through a standard panel test or exome test. Fortunately, there was a targeted drug available for this specific gene. John transitioned to this treatment, which led to positive changes in his prognosis.

Doctor and patient taliking

patient stories

Family finds answers for perplexing symptoms

Andrew, a 1-year-old boy, was experiencing a myriad of perplexing symptoms, including decreased muscle tone, dysmorphism, and a failure to thrive. With the hope of finding answers, Andrew’s provider ordered the RareVision test. The results revealed a pathogenic variant that led to a definitive diagnosis of a rare genetic disorder called Noonan syndrome. This finding provided a roadmap for his future care that allowed his family to take proactive steps in managing his health.

1 Year Old baby

*While all patient names provided are fictionalized to ensure privacy and confidentiality, the age, disease information, and diagnostic process in the testimonials are based on real cases. Please note that clinical outcomes may vary for each individual.

These patient stories are based on collaborative research funded by lnocras.

Frequently asked questions

If you don’t see your question answered here, please contact us.

How can I order a test?

CancerVision tests can be ordered online using our secure portal. Once you fill out the order form, a telehealth provider will review your test order request and the test will be ordered after they review your order and information. Click here to be directed to the order form.

Is the test covered by insurance?

Currently, our whole genome sequencing tests are not yet covered by insurance in the US. We are working on insurance coverage to provide easy access to all patients.

Outside of the US, our products may be covered by insurance, but it varies significantly by the country and types of insurance. We suggest reaching out to your insurer to confirm. If you need any support exploring it, please contact us at inquiry@inocras.com.

How are my samples sent to Inocras?

As a patient, all you have to do is talk with your doctor about the test. Your doctor will then order the test, collect the sample, and send it directly to us. The rest of the process is handled by our team.

What kind of samples are collected, and who collects them?

For CancerVision, we will need a tissue sample and a blood sample. We will work with your pathologist’s office to collect tissue samples. In the order request form, you will need to provide your pathologist office information or your treating oncologist information. With your consent, we can pull the information from your medical records. Your pathologist will get detailed sample collection requirements and instructions.

To collect your blood sample, we provide an at-home blood-draw service, where a phlebotomist will come to your home and collect your blood at your convenience.

For RareVision, you will have the option of choosing your preferred sample collection type when you or your provider order the test. If you choose a blood sample, once your test request is approved, we’ll send you a link to make an appointment for a phlebotomist to visit your home and draw your blood.

If you choose to provide a buccal (cheek) swab, we’ll send you a kit with instructions for you to collect your sample at your convenience.

How will my test results be shared with me?

Once your test is done, your results will be shared with a genetic counselor, who will then share the results with you directly. We will send you an email for you to make an appointment with a genetic counselor and discuss your results.

How long does a test take?

We prioritize delivering results promptly and aim for efficiency in our processes. Our current turnaround time is 14 days from receipt of samples, on average.

This ensures that you receive your results in a timely manner. However, please note that the time from ordering the test to receiving results may vary depending on how long it takes for samples to reach our laboratory.

Will my genetic data be safe?

At Inocras, your privacy matters. We take the protection of your genetic data seriously. Here’s how we keep your information safe:

  • Top-notch security: We implement robust encryption for sensitive portions of your data within our database to protect you.
  • Limited information: We only store essential data to minimize your data footprint.
  • Controlled access: Access to your data is strictly limited to key personnel to protect your privacy.
  • Legal compliance: We follow HIPAA regulations in the US. Keeping your data safe is not just our policy; it’s our legal obligation.
  • Your consent matters: We don’t share your data with anyone else without getting your consent first.
  • Open policies: Our privacy policy is there for you to see on our website. It explains how we use and protect your data.
  • Always up to date: We constantly review and improve our security measures to combat new threats and embrace new safety technologies.

We’re committed to earning your trust by handling your genetic information with the utmost care and respect. If you have questions or need more information about how we protect your data, send us an email at inquiry@inocras.com.